2020
DOI: 10.1136/ebnurs-2020-103281
|View full text |Cite
|
Sign up to set email alerts
|

Modelling suggests that high human papilloma virus (HPV) vaccination coverage in combination with high uptake screening can lead to cervical cancer elimination in most low-income and lower-middle-income countries (LMICs) by the end of the century

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
0
0
0
Order By: Relevance
“…The HPV vaccine can protect ageappropriate females from HPV infection. However, even in some developed countries, the coverage rate of the HPV vaccine remains very low [2,4]. The slow progress of cervical lesion detection and treatment provides a number of very precious opportunities, such as, about 30% of all cervical intraepithelial neoplasia (CIN) level 3 lesions in 30 years progression to invasive cancer [5].…”
Section: Introductionmentioning
confidence: 99%
“…The HPV vaccine can protect ageappropriate females from HPV infection. However, even in some developed countries, the coverage rate of the HPV vaccine remains very low [2,4]. The slow progress of cervical lesion detection and treatment provides a number of very precious opportunities, such as, about 30% of all cervical intraepithelial neoplasia (CIN) level 3 lesions in 30 years progression to invasive cancer [5].…”
Section: Introductionmentioning
confidence: 99%